Aptose Biosciences
Why Robinhood?
You can watch APTOF and buy or sell other stocks, ETFs, and their options commission-free!About APTOF
Aptose Biosciences, Inc. is a clinical-stage oncology company, which engages in the discovery, research, and development of anti-cancer therapies. Its product pipeline includes APTO-253, a small molecule that induces expression of the Kruppel-Like Factor 4 genes; and CG-806 a non-covalent small molecule therapeutic agent.
APTOF Key Statistics
Stock Snapshot
As of today, Aptose Biosciences(APTOF) shares are valued at $1.61. The company's market cap stands at 4.13M, with a P/E ratio of -0.20.
Aptose Biosciences(APTOF) stock opened on 2026-03-18 at —. The price climbed to — and dipped to —.
Aptose Biosciences(APTOF) shares are trading with a volume of 0, against a daily average of 6.65K.
In the last year, Aptose Biosciences(APTOF) shares hit a 52-week high of $4.00 and a 52-week low of $0.64.
In the last year, Aptose Biosciences(APTOF) shares hit a 52-week high of $4.00 and a 52-week low of $0.64.
People also own
Similar Marketcap
This list is generated by looking at the six larger and six smaller companies by market cap in relation to this company.
Popular Stocks
This list is generated by looking at the top 100 stocks and ETFs most commonly held by Robinhood customers and showing a random subset
Newly Listed
This list is generated by showing companies that recently went public.